CME

CME

By ReachMDMedicine
Download on the App Store

CME episodes

  • An Overview of Current and Emerging Treatment Options for Hemophilia A & B
    Host: Stephanie Ambrose, DO
    Guest: Jenny McDaniel, MD

    Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.

    7 min
  • Considering the Promise of New and Emerging Treatments for Hemophilia: The Need for ITI?
    Host: Stephanie Ambrose, DO
    Guest: Jenny McDaniel, MD

    Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.

    8 min
  • Considering the Promise of New and Emerging Treatments for Hemophilia: Managing Thrombotic Risks
    Host: Jenny McDaniel, MD
    Guest: Stephanie Ambrose, DO

    Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.

    7 min
  • Multidisciplinary Team Collaboration in the New Era of Hemophilia Treatment
    Host: Jenny McDaniel, MD
    Guest: Stephanie Ambrose, DO

    Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.

    5 min
  • Moving Forward–What Is on the Horizon? Personalized Therapies for Patients
    Host: Jenny McDaniel, MD
    Guest: Stephanie Ambrose, DO

    Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.

    7 min
  • The Promise and Future of Gene Therapy
    Host: Stephanie Ambrose, DO
    Guest: Jenny McDaniel, MD

    Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.

    6 min
  • Evaluating Novel Factor Replacement Strategies: Extended and Ultra-Half-Life Factors and Factor Mimetics
    Host: Jenny McDaniel, MD
    Guest: Stephanie Ambrose, DO

    Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.

    7 min
  • Evaluating Emerging Treatment Options: Rebalancing Therapies
    Host: Stephanie Ambrose, DO
    Guest: Jenny McDaniel, MD

    Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.

    6 min
  • The Impact of Hemophilia Across Patients’ Lives
    Host: Stephanie Ambrose, DO
    Guest: Jenny McDaniel, MD

    Stay ahead in hemophilia care with the new and emerging therapies transforming treatment approaches. The entire care team should be prepared to apply these innovations in a personalized way. This activity delivers key insights from the recent HTRS meeting along with foundational knowledge on novel therapies, presented in 5-minute modules for easy learning. *This content has not been endorsed by HTRS.

    7 min
  • Enhancing Diagnosis, Treatment, and Outcomes in Paroxysmal Nocturnal Hemoglobinuria with Novel Oral Therapeutics
    Host: Carlos M. de Castro, MD

    Paroxysmal nocturnal hemoglobinuria (PNH) is a rare hematologic disorder characterized by hemolytic anemia and associated with thrombophilia and bone marrow failure. Early and accurate diagnosis and classification of PNH is essential to optimize outcomes. However, the diagnosis of PNH may be delayed or missed for months or even years in practice, and only 25% of newly diagnosed patients receive any PNH-specific treatment. Moreover, up to 20% of patients treated with C5 inhibitors continue to experience clinically significant extravascular hemolysis, leading to residual anemia and its complications. Thus, several new and novel complement inhibitors have been developed and approved. In this activity, Dr. Carlos de Castro reviews the diagnostic criteria for PNH and best practices for the selection of optimal treatment regimens.

    30 min